CPHI Middle East 2026 is the flagship pharmaceutical industry trade fair for the Middle East and Africa, representing the region’s most comprehensive gathering of pharma supply chain professionals. The event spans the complete pharmaceutical ecosystem—from APIs and finished dosage forms to biologics, contract services, packaging solutions, and regulatory compliance.
Co-located with BIO Middle East, the combined exhibition brings together the full spectrum of pharma manufacturing, biotech innovation, and healthcare supply chain decision-makers. The 2026 edition is projected to draw over 60,000 visitors and more than 1,000 exhibiting brands, making it the region’s premier platform for deal-making, sourcing partnerships, and regulatory networking across the Middle East and Africa.
Manufacturers and distributors of active pharmaceutical ingredients, intermediates, and chemical raw materials.
Producers of solid dosage forms, injectables, topicals, and specialized pharmaceutical formulations.
Developers and manufacturers of biologic drugs, biosimilars, vaccines, and advanced therapy medicinal products.
Contract development, manufacturing, and research organizations supporting pharma outsourcing and innovation.
Pharmaceutical packaging solutions, labeling, serialization, and processing equipment manufacturers.
Analytical testing, quality assurance, regulatory consulting, and laboratory equipment suppliers.
Production leaders, operations managers, and manufacturing teams from pharmaceutical companies across the region.
Scientists, researchers, and development leads driving biologic and advanced therapy innovation.
Outsourcing decision-makers evaluating manufacturing, development, and testing partnerships.
Regional pharma distributors, importers, and supply chain managers managing market access across MEA.
Hospital buyers, formulary decision-makers, and regulatory affairs professionals ensuring compliance.
Pharma-focused investors, consultants, and advisors tracking regional market expansion opportunities.
Targets verified pharma manufacturers, biotech companies, CDMOs, distributors, and regulatory professionals.
Contact records are validated and maintained at 95% accuracy.
Engage decision-makers before the exhibition and follow up after sourcing discussions.
Receive campaign-ready datasets aligned with pharmaceutical purchasing and supply chain cycles.
Ideal for outbound sales, ABM campaigns, distributor recruitment, and partnership prospecting.
All data handling follows applicable B2B data protection standards, including GDPR and CAN-SPAM compliance.
Access past and upcoming event editions with verified attendee and exhibitor email lists. Get accurate contact details of event attendees, key decision-makers, and exhibiting companies to power targeted B2B outreach and lead generation.





Our process is designed to deliver accurate, event-specific contact data while maintaining quality, relevance, and compliance at every stage.
We collect contact information exclusively from real expos, trade shows, conferences, and business events using trusted online and offline sources. This ensures our databases are built around active, relevant audiences, not generic or unrelated records.
Once data is collected, missing or incomplete fields are appended to create detailed and usable contact profiles. This includes company details, job roles, industry information, and event relevance to support targeted outreach.
Every contact record goes through validation checks to improve accuracy and reduce outdated or invalid information. Our review process helps ensure better data quality and improved campaign performance.
Target contacts by specific events, industries, job roles, company size, or locations for focused and effective outreach.
Connect with manufacturers, CDMOs, and distributors planning regional expansion.
Engage executives with direct authority over sourcing, manufacturing, and partnership budgets.
Identify buyers evaluating APIs, packaging, biologics, and contract manufacturing partners.
Shorten deal timelines by targeting event-qualified prospects.
Access regional buyers, importers, and distributors attending CPHI Middle East.
Target decision-makers across APIs, finished dosage, biologics, machinery, and regulatory services.
Request curated attendee and exhibitor data from top global trade shows, verified, updated, and ready for targeted outreach.
Click HereOur CPHI Middle East 2026 list includes both exhibitors and attendees. You can purchase the complete database or select specific segments based on your target audience—whether you want to reach exhibitors showcasing their products or attendees looking for sourcing opportunities. Both segments contain verified decision-makers actively participating in the event.
No. CPHI Middle East is explicitly a trade‑only B2B event. It is not open to the general public and is structured around deal‑making, sourcing, and regulatory‑networking across the Middle East and Africa. All attendees and exhibitors are verified pharmaceutical industry professionals, making it a high-quality environment for B2B sales.
Yes. Our CPHI Middle East 2026 data is fully GDPR compliant. We collect and process data in accordance with applicable data protection regulations, including GDPR and local Middle East data privacy laws. All contacts in our database have opted in to receive business communications, and we regularly audit our data sources to ensure compliance. We provide documentation and assurance of compliance upon request.